Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs Immune globulin (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Therapeutic Use
- Sponsors CSL Behring
- 07 May 2019 Status changed from not yet recruiting to recruiting.
- 04 Mar 2019 Planned initiation date changed from 1 Feb 2019 to 1 Mar 2019.
- 05 Feb 2019 Planned initiation date changed from 1 Jan 2019 to 1 Feb 2019.